Common Contracts
2 similar Exclusive License Agreement contracts by Dare Bioscience, Inc.
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • August 13th, 2018 • Dare Bioscience, Inc. • Pharmaceutical preparations • Massachusetts
This Exclusive License Agreement (hereinafter referred to as this “Agreement”), effective as of September 15, 2017 (the “Effective Date”), is entered into by and between Fred Mermelstein, Ph.D. and Janet Chollet, M.D., (collectively referred to as the “Licensors”), Pear Tree Pharmaceuticals, Inc., a corporation duly organized and existing under the laws of the State of Delaware (the “Licensee”), and Stephen Rocamboli (“Rocamboli”).
AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENT FOR ATROPHIC VAGINITIS TECHNOLOGYExclusive License Agreement • August 13th, 2018 • Dare Bioscience, Inc. • Pharmaceutical preparations • Massachusetts
This Amended and Restated Exclusive License Agreement (hereinafter referred to as this “Agreement”), effective as of July 14, 2006 (the “Effective Date”), is entered into by and between Fred Mermelstein, Ph.D. and Janet Chollet, M.D., (collectively referred to as the “Licensors”) and Pear Tree Women’s Health Care, Inc., a corporation duly organized and existing under the laws of the State of Delaware (the “Licensee”) on this August 15, 2007.
